JPMORGAN CHASE & CO – Regeneron Pharmaceuticals, Inc. Transaction History
JPMORGAN CHASE & CO portfolio value:
$3.93B
portfolio value
JPMORGAN CHASE & CO quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +0.48% | 27.43K shares | 573.91M | $688.87 | 5.70M |
Q2 2022 | share | Increase | +14.37% | 713.46K shares | -110.94M | $591.13 | 5.67M |
Q1 2022 | share | Increase | +8.13% | 373.43K shares | 567.99M | $698.42 | 4.96M |
Q4 2021 | share | Increase | +11.92% | 489.08K shares | 416.92M | $642.51 | 4.59M |
Q3 2021 | share | Increase | +8.29% | 314.05K shares | 366.74M | $605.18 | 4.10M |
Q2 2021 | share | Increase | +24.80% | 752.73K shares | 679.67M | $558.54 | 3.78M |
Q1 2021 | share | Increase | +31.16% | 721.26K shares | 318.18M | $473.14 | 3.03M |
Q4 2020 | share | Increase | +20.33% | 391.04K shares | 14.85M | $483.11 | 2.31M |
Q3 2020 | share | Increase | +7.00% | 125.88K shares | -17.73M | $559.78 | 1.92M |
Q2 2020 | share | Increase | +46.21% | 568.05K shares | 520.68M | $623.65 | 1.79M |
Q1 2020 | share | Increase | +0.78% | 9.52K shares | 142.26M | $488.29 | 1.22M |
Q4 2019 | share | Increase | +167.84% | 764.43K shares | 331.70M | $375.48 | 1.21M |
Q3 2019 | share | Decrease | -17.48% | -96.47K shares | -45.12M | $277.4 | 455.45K |
Q2 2019 | share | Decrease | -57.39% | -743.35K shares | -360.40M | $313 | 551.92K |
Q1 2019 | share | Increase | +401.23% | 1.03M shares | 435.34M | $410.62 | 1.29M |
Q4 2018 | share | Increase | +12.55% | 28.80K shares | 3.74M | $373.5 | 258.41K |
Q3 2018 | share | Increase | +51.46% | 78.01K shares | 40.47M | $404.04 | 229.61K |
Q2 2018 | share | Decrease | -7.13% | -11.63K shares | -3.91M | $344.99 | 151.59K |
Q1 2018 | share | Decrease | -24.22% | -52.16K shares | -24.76M | $344.36 | 163.22K |
Q4 2017 | share | Decrease | -37.46% | -129.03K shares | -68.88M | $375.96 | 215.38K |
Q3 2017 | share | Increase | +53.14% | 119.50K shares | 39.39M | $447.12 | 344.41K |
Q2 2017 | share | Decrease | -19.29% | -53.73K shares | 2.48M | $491.14 | 224.91K |
Q1 2017 | share | Decrease | -17.36% | -58.52K shares | -16.17M | $387.51 | 278.64K |
Q4 2016 | share | Decrease | -67.40% | -697.01K shares | -292.36M | $367.09 | 337.17K |
Q3 2016 | share | Decrease | -27.99% | -401.96K shares | -85.02M | $402.02 | 1.03M |
Q2 2016 | share | Decrease | -1.88% | -27.54K shares | -26.03M | $349.23 | 1.43M |
Q1 2016 | share | Decrease | -44.84% | -1.18M shares | -912.99M | $360.44 | 1.46M |